Jeffrey Morrison, MD
Urology · Aurora, CONPI 1174056139
Payments from drug & device makers
Across 90 payments — averaging $62.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Endo Pharmaceuticals Inc.$612
- Antares Pharma, Inc.$513
- Coloplast$322
- Endo USA, Inc.$252
- Teleflex LLC$224
- plus $722 from 10 others
What the payments were for
- Grants$1513%
- Food & beverage$5,45597%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 50 | $2,961 |
| Endo Pharmaceuticals Inc. | 5 | $612 |
| Antares Pharma, Inc. | 8 | $513 |
| Coloplast | 5 | $322 |
| Endo USA, Inc. | 4 | $252 |
| Teleflex LLC | 5 | $224 |
| Innovation Technologies Inc | 2 | $170 |
| SRS Medical Systems, Inc. | 1 | $167 |
| Medtronic | 2 | $126 |
| Axonics, Inc. | 1 | $109 |
| Olympus America Inc. | 2 | $43 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Laborie Medical Technologies Corp. | 1 | $25 |
| 180 Medical, Inc. | 1 | $22 |
| Halozyme Inc | 1 | $18 |
| Urogen Pharma, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIAFLEX$692
- AdVance XP$553
- AMS 700$350
- XYOSTED$266
- TITAN$251
- Advantage System$219
- CT3000 Pro Base Unit$167
- UroCuff-DC Disposable, Single$167
- Irrisept$133
- INTERSTIM$114
- Axonics$109
- Bulkamid$109
How this compares
$5,606 in reported general payments places this provider in the 65th percentile of 225 urology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 16 | $12,904 |
| Methenamine Hippurate | 22 | $1,844 |
| Testosterone | 11 | $1,810 |
| Tamsulosin Hcl | 119 | $1,412 |
| Testosterone Cypionate | 22 | $1,324 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $513 |
| Finasteride | 31 | $376 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $297 |
| Oxybutynin Chloride | 27 | $250 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 52 | $132 |
| Anastrozole | 11 | $55 |
| Cephalexin | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other urology in Aurora
- Paul MaroniAurora$234K
- Brian FlynnAurora$176K
- Al BarqawiAurora$116K
- Janet KukrejaAurora$90K
- Kirk RedgerAurora$24K
- David StraussAurora$16K
- Kerri ThurmonAurora$16K
- David CahnGolden$12.1M
- Lawrence KarshDenver$9.7M
- Alexandra RogersLafayette$541K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.